Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
HealthDay on MSN8d
Clinical Guidelines Updated for Evaluation, Management, Treatment of CKDIn a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
MedPage Today on MSN18d
Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 InhibitorsUse of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization's updated clinical practice guideline. In a synopsis of the recently ...
Clinicians should continue to monitor UACR or UPCR in at-risk children. During periods of rapid growth such as puberty, children with low GFR may show rapid decline in kidney function. Puberty is a ...
Medpage Today on MSN10mon
Many Patients With CKD Never Receive a DiagnosisThis represented 440,749 individuals who met Kidney Disease Improving Global Outcomes (KDIGO) clinical CKD criteria, ...
The Kidney Disease: Improving Global Outcomes (KDIGO) organization updated its 2024 guideline based on an extensive evidence synthesis and meta-analysis conducted by an evidence review team from ...
The full guideline included 28 recommendations for which there is the greatest evidence and 141 practice points, which reflect the expert opinion of the group. HealthDay News — In a 2024 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback